Unrecognized indication for aortic valve neocuspidization: Patient with warfarin-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Karabacak KubilayMurat KadanTuna DemirkıranAyşe Saatçi YaşarMehmet Emin İnceCengiz BolcalPublished in: Journal of cardiac surgery (2022)
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe disorders, characterized by necrosis and epidermal detachment. Most important known acquired etiological factor is medications. Warfarin is one of the most common medications of cardiac valve surgery, which may rarely cause SJS or TEN. From this perspective, Aortic Valve Neocuspidization (AVNeo) procedure may be a good treatment option for such kind of patients, with a unique advantage of anticoagulation free postoperative course. In this report we aimed to share a patient with warfarin-induced STS/TEN, who was successfully treated with AVNeo procedure and mitral valve replacement.
Keyphrases
- aortic valve
- atrial fibrillation
- transcatheter aortic valve replacement
- case report
- venous thromboembolism
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve replacement
- mitral valve
- minimally invasive
- direct oral anticoagulants
- high glucose
- diabetic rats
- oral anticoagulants
- wound healing
- left ventricular
- oxidative stress
- patients undergoing
- heart failure
- early onset
- coronary artery disease
- catheter ablation
- combination therapy
- surgical site infection